LianBio (65) | Collaboration Agreements (4)
Recent Contracts
-
Amendment No. 1 to License and Collaboration Agreement, dated as of September 26, 2022, by and among LianBio Inflammatory Limited and Lyra Therapeutics, Inc
(Filed With SEC on November 10, 2022)
-
Strategic Collaboration Agreement, dated November 17, 2020, by and between LianBio and Pfizer Inc
(Filed With SEC on October 1, 2021)
-
License and Collaboration Agreement, dated May 14, 2021, by and between LianBio Respiratory Limited and Landos BioPharma, Inc
(Filed With SEC on October 1, 2021)
-
License and Collaboration Agreement, dated May 31, 2021, by and among LianBio Inflammatory Limited, LianBio and Lyra Therapeutics, Inc
(Filed With SEC on October 1, 2021)
